A detailed history of Florida Financial Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Florida Financial Advisors, LLC holds 758 shares of LLY stock, worth $606,324. This represents 0.35% of its overall portfolio holdings.

Number of Shares
758
Previous 1,142 33.63%
Holding current value
$606,324
Previous $660 Million 1.75%
% of portfolio
0.35%
Previous 0.4%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Jan 10, 2025

SELL
$772.14 - $960.02 $296,501 - $368,647
-384 Reduced 33.63%
758 $672 Million
Q2 2024

Jan 10, 2025

BUY
$724.87 - $909.04 $103,656 - $129,992
143 Added 14.31%
1,142 $660 Million
Q1 2024

Jan 10, 2025

BUY
$592.2 - $792.28 $76,393 - $102,204
129 Added 14.83%
999 $777 Million
Q4 2023

Jan 10, 2025

BUY
$525.19 - $619.13 $456,915 - $538,643
870 New
870 $507 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $760B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Florida Financial Advisors, LLC Portfolio

Follow Florida Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Florida Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Florida Financial Advisors, LLC with notifications on news.